Detalhe da pesquisa
1.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
; 69(11): e29901, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35989458
2.
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020.
J Transl Med
; 19(1): 144, 2021 04 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33827609
3.
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.
Pediatr Hematol Oncol
; 37(6): 465-474, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32338562
4.
A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.
Pediatr Blood Cancer
; 65(9): e27224, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29856514
5.
Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.
Pediatr Hematol Oncol
; 34(4): 187-198, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29039989
6.
Rhabdomyosarcoma in adults: new perspectives on therapy.
Curr Treat Options Oncol
; 16(6): 27, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25975442
7.
Advances in therapy for pediatric sarcomas.
Curr Oncol Rep
; 16(8): 395, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24894064
8.
Immunotherapy of sarcomas.
Curr Opin Oncol
; 25(4): 390-7, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23736878
9.
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.
Cancer
; 118(23): 5894-902, 2012 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22605650
10.
Management of colorectal carcinoma in children and young adults.
J Pediatr Hematol Oncol
; 34 Suppl 2: S76-9, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22525412
11.
Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.
J Pediatr Hematol Oncol
; 34(5): 395-7, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22584777
12.
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Sarcoma
; 2020: 7935475, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32398945
13.
Malignant melanoma from a nevus of Ota in a pediatric patient with fatal outcome.
J Am Acad Dermatol
; 69(4): e195-7, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24034399
14.
From vision to reality: deploying the immune system for treatment of sarcoma.
Discov Med
; 23(124): 61-74, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28245428
15.
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.
Cancer Med
; 5(2): 294-303, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26714427
16.
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
J Clin Oncol
; 21(19): 3616-22, 2003 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14512392
17.
Hepatic capillariasis in Maine presenting as a hepatic mass.
Am J Trop Med Hyg
; 72(5): 651-3, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15891145
18.
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
J Clin Oncol
; 33(28): 3199-212, 2015 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26169616
19.
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.
Clin Cancer Res
; 21(14): 3178-86, 2015 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25805798
20.
A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate.
Leuk Res
; 28 Suppl 1: S65-9, 2004 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15036944